Long-term outcomes after elective ileocecal resection in children with active localized Crohn's disease--a multicenter European study.

[1]  A. Griffiths,et al.  Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease. , 2014, Journal of Crohn's & colitis.

[2]  A. Griffiths,et al.  Infliximab Maintains Durable Response and Facilitates Catch-up Growth in Luminal Pediatric Crohn's Disease , 2014, Inflammatory bowel diseases.

[3]  C. Calabrese,et al.  Mucosal healing in pediatric Crohn’s disease after anti-TNF therapy: a long-term experience at a single center , 2014, European journal of gastroenterology & hepatology.

[4]  Devinder Kumar,et al.  Resection Leads to Less Recurrence Than Strictureplasty in a Paediatric Population with Obstructive Crohn's Disease , 2014, Surgery research and practice.

[5]  A. Griffiths,et al.  Sa1151 Steroid-Free Remission in Adalimumab-Treated Pediatric Patients With Moderately to Severely Active Crohn's Disease in the IMAgINE 1 Trial , 2014 .

[6]  M. Kamm,et al.  OP023 Optimising post-operative Crohn's disease management: Best drug therapy alone versus endoscopic monitoring, disease evolution, and faecal calprotectin monitoring. The POCER study , 2014 .

[7]  R. Rahhal,et al.  Effects of 70% Ethanol Locks on Rates of Central Line Infection, Thrombosis, Breakage, and Replacement in Pediatric Intestinal Failure , 2014, Journal of pediatric gastroenterology and nutrition.

[8]  N. Afzal,et al.  Surgery for children with Crohn's disease: indications, complications and outcome , 2014, Archives of Disease in Childhood.

[9]  G. Veres,et al.  ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents , 2013, Journal of pediatric gastroenterology and nutrition.

[10]  Alessandro Ventura,et al.  Effect of thalidomide on clinical remission in children and adolescents with refractory Crohn disease: a randomized clinical trial. , 2013, JAMA.

[11]  M. Pakarinen,et al.  Long-term Outcomes After Surgery on Pediatric Patients With Crohn Disease , 2013, Journal of pediatric gastroenterology and nutrition.

[12]  J. Fell,et al.  Disease Phenotype at Diagnosis in Pediatric Crohn's Disease: 5-year Analyses of the EUROKIDS Registry , 2013, Inflammatory bowel diseases.

[13]  A. Duhamel,et al.  Long-term Outcome After First Intestinal Resection in Pediatric-onset Crohn's Disease: A Population-based Study , 2013, Inflammatory bowel diseases.

[14]  M. Nakahigashi,et al.  Enteral nutrition to suppress postoperative Crohn’s disease recurrence: a five-year prospective cohort study , 2013, International Journal of Colorectal Disease.

[15]  A. Griffiths,et al.  Safety and efficacy of adalimumab for moderate to severe Crohn's disease in children. , 2012, Gastroenterology.

[16]  R. Ploeg,et al.  Prevention of postoperative recurrence of Crohn's disease. , 2012, Journal of Crohn's & colitis.

[17]  L. Peyrin-Biroulet,et al.  Diagnosis, prevention and treatment of postoperative Crohn's disease recurrence. , 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[18]  M. Dądalski,et al.  The impact of infliximab induction therapy on mucosal healing and clinical remission in Polish pediatric patients with moderate-to-severe Crohn’s disease , 2012, European journal of gastroenterology & hepatology.

[19]  G. Mattioli,et al.  Strictureplasty and intestinal resection: different options in complicated pediatric-onset Crohn disease. , 2012, Journal of pediatric surgery.

[20]  L. Peyrin-Biroulet,et al.  Review article: the natural history of postoperative Crohn's disease recurrence , 2012, Alimentary pharmacology & therapeutics.

[21]  R. Luchetti,et al.  Natural history of ileo-caecal Crohn's disease after surgical resection. A long term study. , 2011, Minerva gastroenterologica e dietologica.

[22]  David C Wilson,et al.  Pediatric modification of the Montreal classification for inflammatory bowel disease: The Paris classification , 2011, Inflammatory bowel diseases.

[23]  J. Fell.  Update of the management of inflammatory bowel disease , 2011, Archives of Disease in Childhood.

[24]  S. Eaton,et al.  Surgery in Children With Crohn Disease Refractory to Medical Therapy , 2011, Journal of pediatric gastroenterology and nutrition.

[25]  J. Schweizer,et al.  The duration of effect of infliximab maintenance treatment in paediatric Crohn’s disease is limited , 2011, Alimentary pharmacology & therapeutics.

[26]  A. Griffiths,et al.  Factors that determine risk for surgery in pediatric patients with Crohn's disease. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[27]  F. Pruvot,et al.  Pre‐operative management is associated with low rate of post‐operative morbidity in penetrating Crohn’s disease , 2010, Alimentary pharmacology & therapeutics.

[28]  H. Tilg,et al.  The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. , 2010, Journal of Crohn's & colitis.

[29]  C. O'Morain,et al.  The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management. , 2010, Journal of Crohn's & colitis.

[30]  A. Griffiths,et al.  Growth Abnormalities Persist in Newly Diagnosed Children With Crohn Disease Despite Current Treatment Paradigms , 2009, Journal of pediatric gastroenterology and nutrition.

[31]  A. Auvinen,et al.  Long‐term health outcomes in pediatric inflammatory bowel disease: A population‐based study , 2009, Inflammatory bowel diseases.

[32]  Julia Salleron,et al.  Natural history of pediatric Crohn's disease: a population-based cohort study. , 2008, Gastroenterology.

[33]  David C Wilson,et al.  Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. , 2008, Gastroenterology.

[34]  J. Hugot,et al.  12-Month Follow-up After Successful Infliximab Therapy in Pediatric Crohn Disease , 2008, Journal of pediatric gastroenterology and nutrition.

[35]  O. Ogunbiyi,et al.  Limited ileo-caecal resection for localised Crohn's disease in childhood: Clinical outcome and predictors of further surgery. , 2007, Journal of Crohn's & colitis.

[36]  N. Afzal,et al.  Infliximab Delays but Does Not Avoid the Need for Surgery in Treatment-Resistant Pediatric Crohn’ Disease , 2007, Digestive Diseases and Sciences.

[37]  A. Griffiths,et al.  Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. , 2007, Gastroenterology.

[38]  M. Savage,et al.  Clinical Features Affecting Final Adult Height in Patients With Pediatric-Onset Crohn's Disease , 2006, Pediatrics.

[39]  R. Baldassano,et al.  Risk factors for initial surgery in pediatric patients with Crohn's disease. , 2006, Gastroenterology.

[40]  H. Tilg,et al.  The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. , 2010, Journal of Crohn's & colitis.

[41]  P. Munkholm,et al.  Infliximab Dependency in a National Cohort of Children with Crohn's Disease , 2006, Journal of pediatric gastroenterology and nutrition.

[42]  B. Koletzko,et al.  ESPGHAN and ESPEN Guidelines Paediatric Parenteral Nutrition - Annex: List of Products , 2005, Journal of pediatric gastroenterology and nutrition.

[43]  Adrian G. Thomas,et al.  Interventions for growth failure in childhood Crohn's disease. , 2005, The Cochrane database of systematic reviews.

[44]  P. Rutgeerts,et al.  Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial. , 2005, Gastroenterology.

[45]  M. Savage,et al.  Acceleration of linear growth following intestinal resection for Crohn disease , 1990, European Journal of Pediatrics.

[46]  J. Hugot,et al.  Inflammatory bowel disease in children and adolescents: recommendations for diagnosis--the Porto criteria. , 2005, Journal of pediatric gastroenterology and nutrition.

[47]  S. Bosco,et al.  Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease. , 2004, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[48]  P. Lionetti,et al.  Response to infliximab is related to disease duration in paediatric Crohn's disease , 2003, Alimentary pharmacology & therapeutics.

[49]  J. Hugot,et al.  A Prospective Study of the Efficacy and Tolerance of a Chimeric Antibody to Tumor Necrosis Factors (Remicade) in Severe Pediatric Crohn Disease , 2003, Journal of pediatric gastroenterology and nutrition.

[50]  R. Baldassano,et al.  Infliximab (REMICADE) Therapy in the Treatment of Pediatric Crohn's Disease , 2003, American Journal of Gastroenterology.

[51]  R. Baldassano,et al.  Pediatric Crohn's disease: risk factors for postoperative recurrence , 2001, American Journal of Gastroenterology.

[52]  S. Kugathasan,et al.  Prolonged duration of response to infliximab in early but not late pediatric Crohn's disease. , 2000 .

[53]  J. Hyams.  Use of Infliximab in the Treatment of Crohn's Disease in Children and Adolescents , 2000, The Journal of pediatrics.

[54]  J. Cézard,et al.  Postoperative outcome of Crohn’s disease in 30 children , 1998, Gut.

[55]  P. Rutgeerts,et al.  Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. , 1995, Gastroenterology.

[56]  N. Scott,et al.  Timing of ileocolonic resection for symptomatic Crohn's disease--the patient's view. , 1994, Gut.

[57]  M. Corey,et al.  Factors influencing postoperative recurrence of Crohn's disease in childhood. , 1991, Gut.

[58]  J T Boyle,et al.  Development and validation of a pediatric Crohn's disease activity index. , 1991, Journal of pediatric gastroenterology and nutrition.

[59]  P. Rutgeerts,et al.  Predictability of the postoperative course of Crohn's disease. , 1990, Gastroenterology.